Hilliard Lyons Upgrades Bristol-Myers Squibb Co. (BMY) to Long-Term Buy

October 28, 2016 9:26 AM EDT
Get Alerts BMY Hot Sheet
Price: $56.03 +0.86%

Rating Summary:
    10 Buy, 12 Hold, 5 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 27 | New: 28
Trade BMY Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Hilliard Lyons upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Neutral to Long-Term Buy with a price target of $69.00.

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $51.96 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Upgrades

Related Entities

Hilliard Lyons

Add Your Comment